Paying users zone. Data is covered by hidden.

  • Get 1 month access to Abbott Laboratories for $19.99, or

  • get full access to entire website for at least 3 months from $49.99.


We accept:

Visa Mastercard American Express Maestro Discover JCB PayPal Apple Pay Google Pay
Verified by Visa MasterCard SecureCode American Express SafeKey

Microsoft Excel LibreOffice Calc

Abbott Laboratories (ABT)


Long-term (Investment) Activity Analysis

Difficulty: Beginner


Ratios (Summary)

Abbott Laboratories, long-term (investment) activity ratios

Microsoft Excel LibreOffice Calc
Dec 31, 2018 Dec 31, 2017 Dec 31, 2016 Dec 31, 2015 Dec 31, 2014
Net fixed asset turnover hidden hidden hidden hidden hidden
Total asset turnover hidden hidden hidden hidden hidden
Equity turnover hidden hidden hidden hidden hidden

Based on: 10-K (filing date: 2019-02-22), 10-K (filing date: 2018-02-16), 10-K (filing date: 2017-02-17), 10-K (filing date: 2016-02-19), 10-K (filing date: 2015-02-27).

Ratio Description The company
Net fixed asset turnover An activity ratio calculated as total revenue divided by net fixed assets. Abbott Laboratories’s net fixed asset turnover deteriorated from 2016 to 2017 but then improved from 2017 to 2018 exceeding 2016 level.
Total asset turnover An activity ratio calculated as total revenue divided by total assets. Abbott Laboratories’s total asset turnover deteriorated from 2016 to 2017 but then improved from 2017 to 2018 exceeding 2016 level.
Equity turnover An activity ratio calculated as total revenue divided by shareholders’ equity. Abbott Laboratories’s equity turnover deteriorated from 2016 to 2017 but then improved from 2017 to 2018 not reaching 2016 level.

Net Fixed Asset Turnover

Abbott Laboratories, net fixed asset turnover calculation, comparison to benchmarks

Microsoft Excel LibreOffice Calc
Dec 31, 2018 Dec 31, 2017 Dec 31, 2016 Dec 31, 2015 Dec 31, 2014
Selected Financial Data (US$ in millions)
Net sales hidden hidden hidden hidden hidden
Net property and equipment hidden hidden hidden hidden hidden
Ratio
Net fixed asset turnover1 hidden hidden hidden hidden hidden
Benchmarks
Net Fixed Asset Turnover, Competitors2
AbbVie Inc. hidden hidden hidden hidden hidden
Allergan PLC hidden hidden hidden hidden hidden
Amgen Inc. hidden hidden hidden hidden hidden
Biogen Inc. hidden hidden hidden hidden hidden
Bristol-Myers Squibb Co. hidden hidden hidden hidden hidden
Celgene Corp. hidden hidden hidden hidden hidden
Eli Lilly & Co. hidden hidden hidden hidden hidden
Gilead Sciences Inc. hidden hidden hidden hidden hidden
Johnson & Johnson hidden hidden hidden hidden hidden
Merck & Co. Inc. hidden hidden hidden hidden hidden
Pfizer Inc. hidden hidden hidden hidden hidden
Regeneron Pharmaceuticals Inc. hidden hidden hidden hidden hidden
Net Fixed Asset Turnover, Sector
Pharmaceuticals & Biotechnology hidden hidden hidden hidden hidden
Net Fixed Asset Turnover, Industry
Health Care hidden hidden hidden hidden hidden

Based on: 10-K (filing date: 2019-02-22), 10-K (filing date: 2018-02-16), 10-K (filing date: 2017-02-17), 10-K (filing date: 2016-02-19), 10-K (filing date: 2015-02-27).

1 2018 Calculation
Net fixed asset turnover = Net sales ÷ Net property and equipment
= hidden ÷ hidden = hidden

2 Click competitor name to see calculations.

Ratio Description The company
Net fixed asset turnover An activity ratio calculated as total revenue divided by net fixed assets. Abbott Laboratories’s net fixed asset turnover deteriorated from 2016 to 2017 but then improved from 2017 to 2018 exceeding 2016 level.

Total Asset Turnover

Abbott Laboratories, total asset turnover calculation, comparison to benchmarks

Microsoft Excel LibreOffice Calc
Dec 31, 2018 Dec 31, 2017 Dec 31, 2016 Dec 31, 2015 Dec 31, 2014
Selected Financial Data (US$ in millions)
Net sales hidden hidden hidden hidden hidden
Total assets hidden hidden hidden hidden hidden
Ratio
Total asset turnover1 hidden hidden hidden hidden hidden
Benchmarks
Total Asset Turnover, Competitors2
AbbVie Inc. hidden hidden hidden hidden hidden
Allergan PLC hidden hidden hidden hidden hidden
Amgen Inc. hidden hidden hidden hidden hidden
Biogen Inc. hidden hidden hidden hidden hidden
Bristol-Myers Squibb Co. hidden hidden hidden hidden hidden
Celgene Corp. hidden hidden hidden hidden hidden
Eli Lilly & Co. hidden hidden hidden hidden hidden
Gilead Sciences Inc. hidden hidden hidden hidden hidden
Johnson & Johnson hidden hidden hidden hidden hidden
Merck & Co. Inc. hidden hidden hidden hidden hidden
Pfizer Inc. hidden hidden hidden hidden hidden
Regeneron Pharmaceuticals Inc. hidden hidden hidden hidden hidden
Total Asset Turnover, Sector
Pharmaceuticals & Biotechnology hidden hidden hidden hidden hidden
Total Asset Turnover, Industry
Health Care hidden hidden hidden hidden hidden

Based on: 10-K (filing date: 2019-02-22), 10-K (filing date: 2018-02-16), 10-K (filing date: 2017-02-17), 10-K (filing date: 2016-02-19), 10-K (filing date: 2015-02-27).

1 2018 Calculation
Total asset turnover = Net sales ÷ Total assets
= hidden ÷ hidden = hidden

2 Click competitor name to see calculations.

Ratio Description The company
Total asset turnover An activity ratio calculated as total revenue divided by total assets. Abbott Laboratories’s total asset turnover deteriorated from 2016 to 2017 but then improved from 2017 to 2018 exceeding 2016 level.

Equity Turnover

Abbott Laboratories, equity turnover calculation, comparison to benchmarks

Microsoft Excel LibreOffice Calc
Dec 31, 2018 Dec 31, 2017 Dec 31, 2016 Dec 31, 2015 Dec 31, 2014
Selected Financial Data (US$ in millions)
Net sales hidden hidden hidden hidden hidden
Total Abbott shareholders’ investment hidden hidden hidden hidden hidden
Ratio
Equity turnover1 hidden hidden hidden hidden hidden
Benchmarks
Equity Turnover, Competitors2
AbbVie Inc. hidden hidden hidden hidden hidden
Allergan PLC hidden hidden hidden hidden hidden
Amgen Inc. hidden hidden hidden hidden hidden
Biogen Inc. hidden hidden hidden hidden hidden
Bristol-Myers Squibb Co. hidden hidden hidden hidden hidden
Celgene Corp. hidden hidden hidden hidden hidden
Eli Lilly & Co. hidden hidden hidden hidden hidden
Gilead Sciences Inc. hidden hidden hidden hidden hidden
Johnson & Johnson hidden hidden hidden hidden hidden
Merck & Co. Inc. hidden hidden hidden hidden hidden
Pfizer Inc. hidden hidden hidden hidden hidden
Regeneron Pharmaceuticals Inc. hidden hidden hidden hidden hidden
Equity Turnover, Sector
Pharmaceuticals & Biotechnology hidden hidden hidden hidden hidden
Equity Turnover, Industry
Health Care hidden hidden hidden hidden hidden

Based on: 10-K (filing date: 2019-02-22), 10-K (filing date: 2018-02-16), 10-K (filing date: 2017-02-17), 10-K (filing date: 2016-02-19), 10-K (filing date: 2015-02-27).

1 2018 Calculation
Equity turnover = Net sales ÷ Total Abbott shareholders’ investment
= hidden ÷ hidden = hidden

2 Click competitor name to see calculations.

Ratio Description The company
Equity turnover An activity ratio calculated as total revenue divided by shareholders’ equity. Abbott Laboratories’s equity turnover deteriorated from 2016 to 2017 but then improved from 2017 to 2018 not reaching 2016 level.